肌电生物反馈治疗脑卒中患者运动功能障碍的疗效观察  

EMG biofeedback treatment of motor dysfunction in stroke patients Clinical observation

作　　者：龚凌云[1,2] 潘婕[1,2] 吴晓牧[1,2] 吴凌峰[1,2] 曹文峰[1,2] 张昆南[1,2] 

机构地区：[1]江西省人民医院神经内科 [2]江西省人民医院超声诊断科

出　　处：《中华脑血管病杂志（电子版）》2010年第4期13-15,共3页Chinese Journal of Cerebrovascular Diseases(Electronic Edition)

基　　金：十一五国家科技支撑计划资助项目(2008BAI68B03)

摘　　要：目的观察在进行常规药物治疗的同时,早期使用肌电生物反馈疗法辅助治疗脑卒中患者运动功能障碍的疗效。方法对我科2008年5月至2010年1月收治的105例脑梗死及脑出血住院患者进行回顾性分析。其中治疗组55例住院期间使用肌电生物反馈疗法辅助治疗14d。对照组50例未做辅助治疗。两组患者于治疗前后进行简式Fugl-Meyer运动功能评定(FMA)并进行统计分析。结果两组运动功能恢复比较显示治疗组改善较对照组明显,统计学分析差异有显著性(P<0.01)。结论本研究结果表明在进行常规药物治疗的同时,早期使用肌电生物反馈疗法辅助治疗脑卒中偏瘫患者有明显疗效,有利于患者运动功能的康复。Objective To evaluate the therapeutic effectiveness of electromyography （EMG） biofeedback techniques on increasing muscle strength and EMG signal in the stroke patients. Methods 105 stroke patients were divided into two groups. All patients received conventional drug therapy. 55 cases in treatment group received the EMG biofeedback therapy. Each session lasted for 30 minutes,and 14 sessions was a course. Results Muscle strength and EMG signal were significant improved in the treatment group than in the control group （P 〈0.01 ）. Conclusion The EMG biofeedback techniques can significantly increase both muscle strength and EMG signal of the stroke patients. It is beneficial to the rehabilitation of motor function in these patients.

关 键 词：脑卒中 肌电生物反馈 运动功能障碍 

分 类 号：R743.3[医药卫生—神经病学与精神病学]